McKinstry Nancy — SEC Form 4 filings
SEC reporting owner CIK 1294731. 22 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2024-02-01 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Accenture plc (ACN) | Director | 17 | — | — | 20 |
| ABBOTT LABORATORIES (ABT) | Director | 3 | — | — | 6 |
| Mondelez International, Inc. (MDLZ) | Director | 2 | — | — | 2 |
Form 4 filings — McKinstry Nancy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4 | Accenture plc (ACN) | Grant/award (A): 12 @ $0 | EDGAR |
| 2026-05-21 | 4 | Mondelez International, Inc. (MDLZ) | Grant/award (A): 3,525 @ $0 | EDGAR |
| 2026-05-19 | 4 | Accenture plc (ACN) | Grant/award (A): 12 @ $0 | EDGAR |
| 2026-04-28 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 2,286 @ $0 · Grant/award (A): 2,305 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Accenture plc (ACN) | Grant/award (A): 7 @ $0 · Tax withholding (F): 4 @ $224.11 | EDGAR |
| 2026-02-10 | 4 | Accenture plc (ACN) | Tax withholding (F): 398 @ $236.54 | EDGAR |
| 2026-01-29 | 4 | Accenture plc (ACN) | Grant/award (A): 1,212 @ $0 | EDGAR |
| 2025-11-18 | 4 | Accenture plc (ACN) | Grant/award (A): 6 @ $0 | EDGAR |
| 2025-08-18 | 4 | Accenture plc (ACN) | Grant/award (A): 5 @ $247.57 | EDGAR |
| 2025-05-22 | 4 | Mondelez International, Inc. (MDLZ) | Grant/award (A): 3,009 @ $0 | EDGAR |
| 2025-05-16 | 4 | Accenture plc (ACN) | Grant/award (A): 4 @ $0 | EDGAR |
| 2025-04-29 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 1,635 @ $0 · Grant/award (A): 1,465 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Accenture plc (ACN) | Grant/award (A): 4 @ $0 · Tax withholding (F): 2 @ $389.21 | EDGAR |
| 2025-02-07 | 4 | Accenture plc (ACN) | Grant/award (A): 813 @ $0 | EDGAR |
| 2025-02-04 | 4 | Accenture plc (ACN) | Tax withholding (F): 419 @ $383.32 | EDGAR |
| 2024-11-19 | 4 | Accenture plc (ACN) | Grant/award (A): 4 @ $0 | EDGAR |
| 2024-08-16 | 4 | Accenture plc (ACN) | Grant/award (A): 4 @ $0 | EDGAR |
| 2024-05-17 | 4 | Accenture plc (ACN) | Grant/award (A): 4 @ $0 | EDGAR |
| 2024-04-30 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 1,866 @ $0 · Grant/award (A): 6,850 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | Accenture plc (ACN) | Grant/award (A): 4 @ $0 · Tax withholding (F): 2 @ $372.35 | EDGAR |
| 2024-02-05 | 4 | Accenture plc (ACN) | Tax withholding (F): 549 @ $367.33 | EDGAR |
| 2024-02-01 | 4 | Accenture plc (ACN) | Grant/award (A): 859 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1294731 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →